T, C., AE, A., P, K., JD, A., JL, W., T, V., . . . AK, S. (2016). Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. Breast Cancer: Targets and Therapy, 2016(Issue 1), 13-27.
Chicago-referens (17:e uppl.)T, Casneuf, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, och Sasser AK. "Interleukin-6 Is a Potential Therapeutic Target in Interleukin-6 Dependent, Estrogen Receptor-α-positive Breast Cancer." Breast Cancer: Targets and Therapy 2016, no. Issue 1 (2016): 13-27.
MLA-referens (9:e uppl.)T, Casneuf, et al. "Interleukin-6 Is a Potential Therapeutic Target in Interleukin-6 Dependent, Estrogen Receptor-α-positive Breast Cancer." Breast Cancer: Targets and Therapy, vol. 2016, no. Issue 1, 2016, pp. 13-27.
